Controlled release oral preparation with naproxen sodium and pse

Details Controlled release oral preparation with naproxen sodium and pse Controlled release oral preparation with naproxen sodium and pse

2000-01-21

2000-08-08

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

514643, 514569, 424464, A61K 3119, A61K 3114

Patent

active

060998601

ABSTRACT:
Pharmaceutical compositions comprising from about 50 mg to 500 mg of the non-steroidal anti-inflammatory analgesic naproxen and from about 15 mg to 120 mg of the decongestant pseudoephedrine are provided in a controlled release oral preparation suitable for dosing every 12 hours in a therapy or cure of sinusitis, or sinus headaches, generally exemplified by discomfort, pain, pressure, and dizziness.

REFERENCES:
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4619934 (1986-10-01), Sunshine et al.
patent: 5859060 (1999-01-01), Platt
patent: 5998478 (1999-12-01), Platt

Affiliated with

Also associated with

Rating

Controlled release oral preparation with naproxen sodium and pse does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release oral preparation with naproxen sodium and pse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oral preparation with naproxen sodium and pse will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1147820